Meeting
2019 ASCO Quality Care Symposium
Neoadjuvant chemoradiation (NCRT) for esophageal (EC) or gastroesophageal junction cancer (GEJC): A Canadian single institution real-world experience using the CROSS trial regimen.
Authors
Sidra Khalid
Department of Medical Oncology-Queen's University, Kingston, ON, Canada
Sidra Khalid, Wilma M. Hopman, Beatrice Preti, Anna T. Tomiak, Kiran Virik
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cost, Value, and Policy; Health Equity and Disparities
Track
Cost, Value, and Policy,Health Care Access, Equity, and Disparities
Sub Track
Guideline-Concordant Care Initiatives
Citation
J Clin Oncol 37, 2019 (suppl 27; abstr 25)
DOI
10.1200/JCO.2019.37.27_suppl.25
Abstract #
25
Poster Bd #
C4
Abstract Disclosures
Similar Posters
Poster
2020 Gastrointestinal Cancers Symposium
Retrospective comparison of neoadjuvant chemoradiation (nCRT) +/- surgery using the CROSS trial regimen and definitive chemoradiation (dCRT) with carboplatin (C) and paclitaxel (P) in esophageal (EC), and gastroesophageal junction cancer (GEJC) in Canada.
First Author: Sidra Khalid
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Unveiling survival strategies: The impact of treatment modalities on patients with esophageal cancer and the role of racial disparities.
First Author: Dani Ran Castillo
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Induction FOLFOX prior to CROSS chemoradiotherapy and surgery in patients with locally-advanced esophageal and gastroesophageal junction cancer: A phase II study.
First Author: Richard Francis Dunne
Poster
2021 ASCO Quality Care Symposium
Treatment patterns among patients with advanced/recurrent endometrial cancer in the United States.
First Author: Jinan Liu